Intelligent Hospital Pavilion HandbookRight Time
Right Dose
At The 49th ASHP Midyear Clinical Meeting & Exhibition Anaheim,
CA, December 6 - 11, 2014
Right Patient
Right Patient - Right Medication Right Dose - Right Route Right
Time - Right Patient - Right Medication Right Dose - Right Route
Right Time Through The Use Of Technology
TM Pavilion
Intelligent Pharmacy
Produced by
ROOSEVELT UNIVERSITY COLLEGE OF PHARMACY
For more than a decade, Talyst has helped over 500 health
care
systems increase productivity, enhance workflow efficiency,
offer
greater inventory control and improve patient safety. Coupled
with the tremendous cost reduction capabilities available
with
our 340B software and services, Talyst is your trusted partner
in
engineering a safer and more cost effective pharmacy.
We are proud to be a sponsor and exhibit in the Intelligent
Pharmacy™ Pavilion at booth #1777 at the ASHP Midyear Meeting. Stop
by to learn more.
For more information, call 877.4.TALYST x 1 or
[email protected].
Visit talyst iN booth #301 at ashP Learn how we are helping health
care systems across the country improve productivity, efficiency,
inventory control and patient safety.
Welcome - Paul Abramowitz, CEO, ASHP - Harry Pappas, CEO &
President, IHA
Welcome - Anne Olscher, COO, IHA
.......................................................
The Intelligent PharmacyTM Overview By Shannon John Johnson,
Pharm.D.
.........................................................
The Intelligent PharmacyTM Advisory Board
................................................
The Intelligent PharmacyTM Use Cases
......................................................
Is Your Hospital Pharmacy a Strategic Asset? By Mary Baxter, MBA,
R.Ph.
......................................................................
Interview with Glenn Aspenns - The Five Rights
.........................................
The Internet’s Democratization of Medicine By Ashish Advani
....................................................................................
Embracing New and Emerging Technologies in Pharmacy Curricula By
George E. MacKinnon III, Ph.D., R.Ph., FASHP
......................................
Diversion: Understanding and Mitigating the Risk By Kimberly New,
JD, BSN, RN
..................................................................
IV Compounding: the Last Frontier of Pharmacy Automation By John
Barickman, R.Ph., MBA, FACHE
....................................................
Leveraging the Power of Information - Standardizing Data in
Healthcare Processes for Safer Care - By GS1
.............................................................
What is the IHA?
The Intelligent Health Association (IHA) is a global, technology
based and technology focused organization comprised of many new
technology communities and societies all operating under one
organizational structure with a common goal: to help drive the
“Evolution to the Health Revolution™ ” through the adoption and
implementation of new technologies in the health Eco-system. The
IHA will accomplish this goal through the delivery of vendor
neutral, technology agnostic educational programs in a partnership
with the other health related organizations, academic institutions,
government, technology community, and standards bodies.
For further information please contact Harry P. Pappas, CEO, The
Intelligent Health Association:
[email protected]
All rights reserved. All trademarks and copyrights in this
publication are recognized, and acknowledged where possible. Any
materials, written, digital, photographic and illustrative
submitted are accepted on the basis of a worldwide right to publish
in printed or electronic form. All contents copyright the
Intelligent Health Association ©2014, and/or the respective
copyright holder. No part of this document may be reproduced
without written consent from the Intelligent Health Association, or
the respective copyright holder, where applicable. The views
expressed in this issue are those of the contributors and not ASHP
or the Intelligent Health Association.
Cover design, art direction, layout, additional illustration and
handbook content compilation by Andrew Neil Olscher, VP Media &
Publications, The Intelligent Health Association. Individuals
appear in photographs for illustrative purposes only and such
appearance does not constitute an endorsement of any product,
service or opinion detailed, offered or expressed within this
publication, or The Intelligent PharmacyTM Pavilion.
FEATURE ARTICLES
PAGE 13
Right Patient Right Medicine Right Dose Right Route Right
Time
4 4
Right Dose Right Route Right TimeRight Patient - Right
Medicine
Right Dose - Right Route Right Time - Right Patient - Right
Medicine Right Dose - Right Route Right Time Right Patient - Right
Medicine Right Dose - Right Route Right Time - Right Patient -
Right Medicine Right Dose - Right Route Right Time
M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M AutoID RFID BLE RTLS Wireless
Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano NFC M2M
AutoID RFID BLE RTLS Wireless Sensors BLE Biometrics M2M AutoID
RFID RTLS Wireless Nano M2M AutoID RFID BLE RTLS Wireless Sensors
Biometrics M2M AutoID RFID RTLS Wireless Nano M2M AutoID RFID BLE
RTLS Wireless Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano
NFC M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M AutoID RFID BLE RTLS Wireless
Sensors BLE Biometrics M2M AutoID RFID RTLS Wireless Nano M2M
AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID RFID
RTLS Wireless Nano
Right Patient Right Medicine
at ASHP Mid-Year Meeting
M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M utoID RFID BLE RTLS Wireless
Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano NFC M2M
AutoID RFID BLE RTLS Wireless Sensors BLE Biometrics M2M AutoID
RFID RTLS Wireless Nano M2M AutoID RFID BLE RTLS Wireless Sensors
Biometrics M2M AutoID RFID RTLS Wireless Nano
Right Time
Right Route
Right Dose
Right Medicine
Right Patient
Intelligent Pharmacy TM
TABLE of CONTENTS
THE INTELLIGENT PHARMACY TM - A production of the Intelligent
Health Association 2
INTELLIGENT HEALTH ASSOCIATION Healthier Living Through Technology
TM
How It Works
Each item is tagged in the pharmacy or by a third party repackager
prior to arriving at the hospital.
Medications are placed into kits. Each kit is placed in the
scanning station for 5 seconds before and after restocking.
1
2
Kit Check shows exactly which items were used, which are nearing
expiration and which need to be replaced.
Kit Check automatically generates your charge sheet and eliminates
manual medication expiration recording.
3
4
Kit Check is the leader in hospital pharmacy kit automation and
medication tracking software. Kit Check helps hospital pharmacists
replace manual processes with faster and safer cloud-based
technology solutions that are easy to implement and use.
o. 786-KIT-CHECK (786-548-2432) e.
[email protected]
kitcheck.com
Fast and Friendly Kit Processing
72%-90% Faster Kit Processing
99.5% Higher Kit Accuracy
$4.07 Savings per Medication
By The Numbers
Safety & Accuracy Improve pharmacy kit accuracy and increase
patient safety by reducing
adverse drug event risk. Customers have improved kit accuracy from
92%
to over 99.9%.
Shortages & Recalls Manage shortages and drug substitutes
centrally and know instantly
which kits are missing key medications. If there is a recall,
simply enter the
NDC and lot number to locate impacted kits. Customers have cut
recall
handling time by as much as 93%.
No IT Involvement You don’t have to wait for the IT department. Kit
Check is a web-based
application in the cloud. It does not require any on-site servers.
Simply
plug in the scanning station and use any hospital PC to securely
access
the system.
PAGE 27
Is Your Pharmacy Ready for FDA’s DSCSA 2015 Implementation? By USDM
...................................................................................................
Leaders Challenge the Current Case Study - Aesynt
.....................................................................................
IV Room Barcoding and Improved Pharmacy Productivity Case Study -
Baxter
.....................................................................................
Integrating Technology - SIGMA Spectrum Infusion System Integrates
into Cerner - Case Study - Baxter
....................................................
CSTD Performance Impacts Healthcare Worker Safety Case Study - BD
..........................................................................................
Increase Use of Ready-to-Administer Prefilled Injectables Case
Study - BD - By Keith P. Shuster, R.Ph., MBA
.............................................
Improve Infusion Safety and Reduce Alarm Fatigue in the ICU Case
Study - B Braun
....................................................................................
Forget Smart Phones - What You Need are Smart Pumps! Case Study - B
Braun
...................................................................................
Smart Pumps - Achieving 100% Drug Library Compliance and Averting
Medication Errors - Case Study - B Braun
......................................................
Medication Infusion Safety Through Technology and Practice Case
Study - B Braun
....................................................................................
Controlling Drug Costs - Transforming the Pharmacy into a Strategic
Asset Case Study - Cardinal Health
................................................................................
Changing the Standard of Care - Bedside Discharge Prescriptions
Improves Patient Care - Case Study - Cardinal Health
...................................................
Wireless Interoperability Helps Optimize Intravenous Infusion
Safety, Documentation and Management - Case Study - CareFusion
..........................
Best Practices in Medication Management Case Study - CareFusion
..............................................................................
Pharmacy Kit Restocking Automation Improves Efficiency and Safety
Case Study - KITCHECK
..............................................................................
Electronic TLC: Toronto Hospital Increases Patient Safety With
eCare Project Case Study - Motorola
................................................................................
Leaders Challenge The Current
Children’s Hospitals and Clinics of Minnesota (Children’s
Minnesota), partnering with CareFusion and Cerner,
became the first pediatric hospital system to achieve
interoperability between smart intravenous (IV) infusion
pumps and an electronic health record (EHR) system.
Children’s Minnesota is also the first hospital of any type
to implement infusion interoperability for both
large-volume and syringe IV infusions. The state’s largest
provider of neonatal, cancer, diabetes and cardiac care,
Children’s Minnesota is a nonprofit, independent pediatric
health system with 381 inpatient beds, 1,700 professional
staff, 12,218 inpatient admissions, 20,453 surgical cases,
403 active research programs and approximately $590 M in
annual revenue.
Following its successful pilot study in a PICU in March 2012,
Children’s Minnesota has implemented smart pump-EHR
interoperability for all 381 inpatient beds throughout its
Minneapolis and St. Paul hospitals, including ICUs, medical/
surgical units, short-stay units, the ER and surgical
services
for acutely ill pediatric patients ranging from 400-g
neonates to 150-kg adolescents. The goal is to continually
increase medication safety while reducing costs, using
technology to help decrease costly adverse drug events
(ADEs) by 10% to 15% per year.
High-risk IV infusions present much greater medication
safety challenges than non-infusion medications.1 IV
infusion errors, which involve high-risk medications
delivered directly into a patient’s bloodstream, are the
medication errors with the greatest potential to cause
harm—especially for pediatric and neonatal patients
requiring precise weight-based dosing.2 Traditional
barcode medication administration (BCMA) systems,
PAGE 49
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013 Alerts by Drug
2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
Alerts by Drug 2013
Aborts Overrides Corrections
Reduction in alerts for target drugs: • 88% reduction in heparin
ACS alerts • 88% reduction in fentanyl alerts • 48% reduction in
RBC alerts • 45% reduction in dexmedetomidine
alerts • 63% reduction in propofol alerts
Overrides by Drug 2013
Compliments of:
Outlook and DoseTrac are registered trademarks of B. Braun Medical
Inc. 13-3746A_4/13_BB
Objective Medication safety is a primary goal for our system of 4
major medical centers in the New York City area. To reduce errors
associated with IV infusion, we evaluated several infusion pumps
with smart pump technology and selected the B. Braun Outlook® 400ES
based on the following key safety features:
• real time data monitoring • wireless retrospective
reporting
software • ease of use • light-weight, single channel device
After implementation, we used the real time view and retrospective
infusion data to identify opportunities to further enhance patient
safety.
Methods A multidisciplinary team from all hospital sites met weekly
to standardize our hospital formulary, including drug
concentrations, diluents, and weight-based dosing. The new
formulary was updated in our electronic medical record and
computerized physician order entry. A smart pump drug library was
created with input from various departments, establishing
parameters such
as soft and hard dosing limits, clinical advisories, and bolus
dosing. We created a single, uniform drug library for all smart
pumps across our system.
DoseTrac® Real Time and Retrospective Data Real time monitoring
allowed us to see all of our infusions, confirm whether they were
programmed in the drug library, and immediately identify if any
infusions were outside the dosing limits. We were pleased to find
drug library utilization in critical care at 100%. Retrospective
reports allowed us to identify trends with drug library
utilization, dose overrides, corrections, and top drugs associated
with alerts. Six month data analysis (Jan – June 2012) showed the
following:
429 corrections (7%)
5,351 overrides (93%)
• Few dose corrections indicate low incidence of programming
error
• Only 3 insulin corrections over 6 months!
• High number of overrides led us to look at our soft limits and
practices
Alerts by Drug 2012
• 493 heparin ACS overrides - exceeding soft limit of 1000
units/hr
• 46 fentanyl “good catches”- all corrected to within the soft
limits
• 396 RBCs overrides – 52% due to infusing 80-100 ml/hr (soft max
75 ml/hr)
• 198 dexmedetomidine overrides – exceeding soft limits and bolus
dosing
• 250 propofol overrides – 23% due to bolus dosing
• 2988 bolus doses - using bolus feature
Results Significant reduction in alerts was achieved through dosing
limit modifications, education on use of bolus feature, cheat sheet
for staff, and distribution of weekly DoseTrac reports to pharmacy,
nursing, and administration.
Forget Smart Phones – What You Need Are Smart Pumps! Cathy
Sullivan, RN, NP, Director of Patient Care Services, Beth Israel
Medical Center, New York, NY
Presented at the American Association of Critical-Care Nurses
National Teaching Institute, May 2013
LEADERS CHALLENGE
THE CURRENT
About Aesynt
A customer-focused, innovative organization, Aesynt provides
hospitals and health systems with high-quality, cost- effective and
efficient solutions that safely deliver the right medication
closest to the patient.
Founded in 1987, acquired by McKesson in 1996, and now owned by
Francisco Partners, a technology-focused private equity firm,
Aesynt has been a leader in pharmacy automation for more than 25
years.
At Aesynt, we understand hospitals and health systems are facing
complex issues. Helping solve those challenges is our top priority.
Our sole focus is on helping health care providers meet their
biggest challenges – delivering quality care, reducing costs and
operating more efficiently.
As a market leader in pharmacy automation and medication
management, we know the health care industry inside and out, and
understand how the evolving health care landscape affects you and
your business.
We were the first company to offer a robotic, barcode- based
solution for medication dispensing, and we now boast an integrated
flexible portfolio of solutions to address every stage of
medication delivery, whether in a single hospital or across
multiple facilities, and regardless of medication type.
Through automation and information management, we provide an
enterprise solution that offers visibility, control and flexibility
into how you buy, store, package, compound, track and deliver
medication, from high- volume, unit-dose oral solids to high-risk,
high cost injectable medications across the medication supply
chain.
TMAesynt is pleased to sponsor the Intelligent Pharmacy Pavilion
and the
Aesynt Leadership Theater at the 2014 ASHP Midyear Clinical Meeting
& Exhibition
Solving Complex Medication Management Challenges for Health
Systems
CONT’D
Right Dose Right Route Right TimeRight Patient - Right
Medicine
Right Dose - Right Route Right Time - Right Patient - Right
Medicine Right Dose - Right Route Right Time Right Patient - Right
Medicine Right Dose - Right Route Right Time - Right Patient -
Right Medicine Right Dose - Right Route Right Time
M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M AutoID RFID BLE RTLS Wireless
Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano NFC M2M
AutoID RFID BLE RTLS Wireless Sensors BLE Biometrics M2M AutoID
RFID RTLS Wireless Nano M2M AutoID RFID BLE RTLS Wireless Sensors
Biometrics M2M AutoID RFID RTLS Wireless Nano M2M AutoID RFID BLE
RTLS Wireless Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano
NFC M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M AutoID RFID BLE RTLS Wireless
Sensors BLE Biometrics M2M AutoID RFID RTLS Wireless Nano M2M
AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID RFID
RTLS Wireless Nano
Right Patient Right Medicine
at ASHP Mid-Year Meeting
M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M utoID RFID BLE RTLS Wireless
Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano NFC M2M
AutoID RFID BLE RTLS Wireless Sensors BLE Biometrics M2M AutoID
RFID RTLS Wireless Nano M2M AutoID RFID BLE RTLS Wireless Sensors
Biometrics M2M AutoID RFID RTLS Wireless Nano
Right Time
Right Route
Right Dose
Right Medicine
Right Patient
Intelligent Pharmacy TM
A production of the Intelligent Health Association 4THE INTELLIGENT
PHARMACY TM -
Welcome From Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHP CEO,
ASHP
Welcome to the ASHP Midyear Clinical Meeting and the first-ever
Intelligent Pharmacy Pavilion (IPP).
We are excited to host this innovative exhibit that will provide
you with a unique look at the ways that technology can be utilized
to prevent errors and improve safety for your patients.
This 8,000 square-foot pavilion features demonstration rooms
showcasing the latest technologies utilized in today’s hospitals
and ambulatory care clinics. The IPP will give you a chance to
observe the integration of medication management technology and
patient care delivery.
The Midyear, the world’s largest gathering of pharmacists, is the
perfect setting for the IPP. I encourage you to take advantage of
the exceptional educational programming and dynamic networking
opportunities that the meeting offers. Use the program book or the
ASHP Live meeting app to help you navigate everything happening
this week.
Thank you for joining us at the Midyear. Enjoy your interactive
tour of the Intelligent Pharmacy Pavilion!
The senior management of the Intelligent Health Association (IHA)
(www.ihassociation.org), the senior executives of the ASHP
organization, along with our many supporting technology sponsors
welcome you to the launch of this destination pavilion: “The
Intelligent Pharmacy” Pavilion at ASHP 2014.
As the Founder and CEO of the Intelligent Health Association (IHA),
I am very pleased to welcome you to ASHP’s newest educational,
technology centric, destination pavilion: the “Intelligent
Pharmacy” Pavilion.
The IHA is an international, educational, vendor neutral,
technology centric association dedicated to promoting, through
educational programs, the adoption of new technologies in the
health community for the improvement of patient care and patient
safety through the use of technologies.
You may already know our organization, the Intelligent Health
Association (IHA), as the developer of a similar, very successful,
destination pavilion: The “Intelligent Hospital Pavilion” and the
“Intelligent Medical Home” pavilion that we produce and present at
the annual www.HIMSS.org trade show and conference. Visit:
www.intelligenthospital.tv and view our many videos.
I would like to acknowledge and thank, my friend and industry
thought leader, Dr. John Johnson, of Sharp Memorial Hospital, San
Diego, CA for serving as the chairman of the steering committee and
for developing and guiding all aspects of the “Intelligent
Pharmacy” Pavilion. Along with Dr. Johnson, I would also like to
thank his team of industry leaders, deans and academicians from a
number of schools of pharmacy, the FDA, State Board of Pharmacies
and his group of progressive thinking technology vendors. We all
are grateful to Dr. Johnson for giving his time and for helping
educate his colleagues. Dr. Johnson and his team are bringing great
change to the hospital pharmacy community, while at the same time
helping to improve patients’ lives through the adoption of new
technologies in the hospital pharmacy. He is part of the “Evolution
to the Healthcare Revolution”™.
I also thank the ASHP leadership for their vision in working with
the IHA team to create this educational “Intelligent Health- System
Pharmacy” Pavilion.
If you would like to join our educational team for ASHP 2015 and to
assist us in planning future educational programs, please let us
know by dropping me a note at:
[email protected]
Thank you for visiting and touring YOUR “Intelligent Pharmacy”
Pavilion.
INTELLIGENT HEALTH ASSOCIATION Healthier Living Through Technology
TM
Welcome From Harry P. Pappas Founder and CEO of the Intelligent
Health Association
5 A production of the Intelligent Health Association THE
INTELLIGENT PHARMACY TM -
As COO of the Intelligent Health Association, I’m delighted to
welcome you to the launch of the Intelligent Pharmacy Pavilion
(IPP) at the ASHP Midyear Clinical Meeting. The IPP is the result
of close partnerships with pharmacists, nurses, administrators and
industry to showcase how existing and emerging technologies can be
combined and integrated most effectively in the real world.
Our goal is to help raise the level of awareness of technologies
that make healthcare more efficient, effective and comprehensive
via wireless information delivery, as well as medical devices,
wireless sensors applications and Auto-ID RFID/RTLS platforms. The
integrated technology and solutions displayed and demonstrated at
the pavilion are designed not only to improve patient care in the
hospital, but to assure the wellness of that patient even after he,
or she, goes home.
The pavilion will provide demonstrations of diverse technologies
and systems, and show how they can be integrated through a series
of use case demonstrations, highlighting the impact in workflows,
patient care and data sharing between the central or facility
pharmacy and the healthcare provider. The tours will incorporate a
variety of use cases which demonstrate how technology helps ensure
that the correct medication and dose gets to the right patient, at
the right time and via the right route.
In addition to tours, we have an exciting line-up of speakers in
the Aesynt Leadership Theater, with sessions running every 20
minutes during exhibit hall hours. In keeping with our mission to
continue delivering educational programs, as well as to sponsor
research and collaborate with standards bodies to ensure
technologies provide the benefits most needed in the healthcare
community, we have partnered with three universities.
Representatives will be present in our pavilion, fielding questions
on their schools of pharmacy.
Please plan to stop by our pavilion.
INTELLIGENT HEALTH ASSOCIATION Healthier Living Through Technology
TM
Welcome From Anne Olscher COO, The Intelligent Health
Association
Come see us at ASHP booth #1101
BD Pharmacy Solutions Pharmacy solutions now... for healthcare’s
tomorrow.
BD and BD Logo are trademarks of Becton, Dickinson and Company. ©
2014 BD MSS0639a (10/14)
BD Medical 1 Becton Drive Franklin Lakes, NJ 07417 www.bd.com
What’s the secret to surviving in healthcare? Always knowing your
next move. There’s no doubt—healthcare is evolving into an entirely
different game. More and more, you’ll be tasked to improve quality,
while keeping costs under control. Does that seem like a losing
battle? Not if you have the right strategy and partner. BD Pharmacy
Solutions is on the front lines with you. Because in a changing
game, your next move is more important than ever.
Innovative solutions for: • Patient and healthcare worker safety •
Workflow efficiency • Cost containment
14-BEC00-02-0004_ASHP JournalAd_CHESS-8x5.125.indd 1 10/15/14 10:12
AM
A production of the Intelligent Health Association 8
THE INTELLIGENT PHARMACY™ Overview A production of the Intelligent
Health Association - a not-for-profit, educational
organization
Shannon “JJ” Johnson, Pharm.D. Director of Pharmacy, Intelligent
Health Association
Welcome to the first ever Intelligent Pharmacy Pavilion at an ASHP
meeting. The pavilion we’ve built for you includes two full-size
pharmacies and a nursing unit, similar to the ones you all probably
work in every day. As every health-system pharmacist knows, complex
systems contribute to human errors and pharmacy is only getting
more complex by the day. Medication misadventures happen at any
number of critical steps in the delivery of care. In the
Intelligent Pharmacy at the ASHP Midyear Clinical Meeting you will
see examples of these challenges combined with interesting and
innovative solutions. Some of these solutions will be emerging
technologies geared to increase patient safety and operational
efficiencies. Others will focus on improving the pharmaceutical
supply chain from ordering all the way to the patient’s bedside.
Tour participants will watch and listen as live pharmacist and
pharmacy technician actors perform their daily duties while
interacting with various technologies that help them to be more
efficient and accurate at every stage of the medication use
process.
While this method of showing medication-use related technology in
action with real live actors in a fully built out pharmacy is new
to ASHP, it’s not new to the industry. It actually began about four
years ago at the Health Information Management Systems Society
(HIMSS) annual meeting and just two years ago we launched our first
pharmacy demonstration. It was such a success we’re fortunate to
have been given the opportunity to bring it to the ASHP Midyear
Clinical Meeting this year, albeit with a special new twist. While
we’re showing the traditional hospital or “facility” pharmacy you
would see in any hospital, we’ve also added a “central” pharmacy.
Known also as a “hub-and-spoke” model, the central pharmacy is
designed to support many facility-based pharmacies throughout a
health-system. This model is becoming more common these days as
health-systems realize the advantage of aggregating some services
together while reducing duplicate inventory at each facility.
We invite you to tour the pavilion and see real solutions to
current problems health-system pharmacists face every day. We hope
it will spark an idea or a thought in your mind on how to solve a
problem you might be facing.
Dr. Shannon “JJ” Johnson is Director of Pharmacy for Sharp Memorial
Hospital in San Diego, California. Sharp Memorial is a level 2
trauma center with over 380 staffed acute care beds and is one of 7
hospitals within the Sharp system. Dr. Johnson leads a team of over
70 of the best pharmacists and pharmacy technicians in San Diego
that promotes safety and safe medication use as one of their core
pillars of excellence. Sharp is also recognized by Hospitals &
Health Networks Magazine’s 2013 Most Wired, and was a 2007 Malcolm
Baldrige National Quality Award winner.
INTELLIGENT HEALTH ASSOCIATION Healthier Living Through Technology
TM
Intelligent Pharmacy Pavilion Advisory Board and Steering
Committee
John Johnson, Pharm.D. - Chairman - Director of Pharmacy, Sharp
Memorial Hospital, San Diego
Anne Olscher - Co-Chair - COO, The Intelligent Health
Association
Chris Chandler, Pharm.D. - Co-Chair - VP of Healthcare Solutions
and Services at USDM Life Sciences
Harry P. Pappas - Founder and CEO of the Intelligent Health
Association
Paul Frisch, PH.D. - Chief, Biomedical Physics and Engineering
Service,
Memorial Sloan Kettering Cancer Center, New York
George McKinnon III, Ph.D., R.Ph, FASHP - Founding Dean and
Professor College of Pharmacy,
Vice Provost Health Sciences, Roosevelt University, Schaumburg,
IL
Troy Reiff, RN - COO, RFID in Healthcare Consortium
Ashish Advani, Pharm.D., R.Ph., Pharmacist and Assistant
Professor,
Mercer University College of Pharmacy, Atlanta, GA
THE INTELLIGENT PHARMACY TM -
Right Patient Right Medicine
Right Dose Right Route Right TimeRight Patient - Right
Medicine
Right Dose - Right Route Right Time - Right Patient - Right
Medicine Right Dose - Right Route Right Time Right Patient - Right
Medicine Right Dose - Right Route Right Time - Right Patient -
Right Medicine Right Dose - Right Route Right Time
M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M AutoID RFID BLE RTLS Wireless
Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano NFC M2M
AutoID RFID BLE RTLS Wireless Sensors BLE Biometrics M2M AutoID
RFID RTLS Wireless Nano M2M AutoID RFID BLE RTLS Wireless Sensors
Biometrics M2M AutoID RFID RTLS Wireless Nano M2M AutoID RFID BLE
RTLS Wireless Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano
NFC M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M AutoID RFID BLE RTLS Wireless
Sensors BLE Biometrics M2M AutoID RFID RTLS Wireless Nano M2M
AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID RFID
RTLS Wireless Nano
Right Patient Right Medicine
at ASHP Mid-Year Meeting
M2M AutoID RFID BLE RTLS Wireless Sensors Biometrics M2M AutoID
RFID RTLS Wireless Nano NFC M2M utoID RFID BLE RTLS Wireless
Sensors Biometrics M2M AutoID RFID RTLS Wireless Nano NFC M2M
AutoID RFID BLE RTLS Wireless Sensors BLE Biometrics M2M AutoID
RFID RTLS Wireless Nano M2M AutoID RFID BLE RTLS Wireless Sensors
Biometrics M2M AutoID RFID RTLS Wireless Nano
Right Time
Right Route
Right Dose
Right Medicine
Right Patient
Central Pharmacy/Supply Chain Room - Hub-And-Spoke Pharmacy Supply
Chain Model
Omnicell: Central Pharmacy Manager Requested items from within the
entire healthcare system populate the prioritized picking queue,
and then guide the pharmacy tech to pick those items. Once all the
items are picked, those items are delivered to the appropriate
location.
Talyst: AutoVault Mini w/AutoCool i.H With your AutoPharm®
Enterprise inventory system, AutoVault w/AutoCool provides secure
access to medications (including controls and refrigerated
medications) in central pharmacies, remote pharmacies, satellite
pharmacies, outpatient clinics, and specialty clinics and fully
integrates the transaction data for streamlined reporting and
ordering.
Central Pharmacy Compounding Lab
AESYNT: i.v.SOFT®
i.v.SOFT® is a family of software solutions that bring the benefits
of automation to manual compounding and dispensing. i.v.SOFT
increases medication safety with enhanced dosage and diluent
accuracy, while improving the quality and efficiency of IV
workflow.
B. Braun Medical Inc.: Computerized Physician Order Entry of
Parenteral Nutrition Orders Pinnacle TPN Manager is the only CPOE
and Pharmacy software with Trissel’s Calcium-Phosphate Safety
Check. It automates calculations to streamline the prescribing of
parenteral nutrition from order entry to infusion from physician to
patient.
Baxter Healthcare: DoseEdge Pharmacy Workflow Manager: Complete
Pharmacy Workflow Solution The DoseEdge System is an enterprise
solution that manages the workflow for dose routing, preparation,
inspection, tracking and reporting on IV and oral liquid doses. By
providing visibility to the entire dose preparation and dispensing
process for both patient- specific and stock doses, the DoseEdge
System helps promote dose preparation safety, reduce waste and
enhance pharmacy productivity.
Facility Pharmacy - Traditional Inpatient Pharmacy
Kit Check: Medication Kit and Tray Vending and Deployment Kit Check
drives efficiency and patient safety improvements in hospital
pharmacies by automating the slow, manual, error-prone kit
replenishment process and eliminating kit medication errors. Our
flexible software efficiently manages drug shortages, recalls and
expiring medications.
Talyst: AutoPharm Enterprise w/AutoCarousel Mini AutoPharm®
Enterprise, a powerful software platform, provides enterprise-wide
medication management across your entire health system to offer
greater inventory control, enhanced workflow efficiency, and
improved patient safety. AutoCarousel® Mini provides secure,
automated storage for all your medications. This demonstrates the
concept of high density automated storage as well the specific Mini
product which is perfect for compact spaces.
CareFusion: Track and Deliver “Where’s my med?” – the most common
question Nursing asks Pharmacy. By providing visibility for all
medications in transport from Pharmacy to the Nursing unit, Pyxis®
ES Link Track and Deliver can help improve communication, enhance
nursing efficiency and reduce medication waste.
Intelligent PharmacyTM
USE CASES
9 A production of the Intelligent Health Association THE
INTELLIGENT PHARMACY TM -
Cardinal Health: Remote Pharmacy Services
From the pioneers in Remote Pharmacy Services. With Cardinal Health
Remote Order Entry Service, you can ensure every medication order
is thoroughly reviewed by a hospital-trained pharmacist - any time,
day or night to ensure continuity of care.
Cardinal Health: Drug Cost Opportunity Analytics Drug Cost
Opportunity Analytics is a web-based dashboard that helps pharmacy
leaders identify pharmacy drug cost and use drivers, outlier
performance, cost savings opportunities and improve forecasting
capabilities, as well as benchmark performance.
Baxter Healthcare: ICNet Relevant information. Continual
monitoring. Quality-of-care metrics. ICNet clinical surveillance
software provides you the insight to make more informed decisions
on medication usage and infection prevention measures. Come see the
power and flexibility of this tool.
PharmView: Real Time Status View of IVs for Pharmacy IV Admixture
Services
PharmView provides visibility to infusion data in real-time. With
updates every 3 seconds, schedule your preparations based on actual
time due, minimizing urgent requests and waste. Data fields and
alerts are fully customizable.
Compounding Lab In The Facility Pharmacy BD: BD Cato Medication
Workflow Solutions
BD Cato™ Medication Workflow Solutions is an innovative
gravimetric-based, barcode verification-enabled workflow solution
that enhances safety and workflow efficiency of preparation of IV
medications by detecting wrong drug and wrong dose errors in real
time.
BD: BD PhaSeal Closed System Drug Transfer Device BD PhaSeal™
Closed System Drug Transfer Device (CSTD) is proven to reduce
healthcare workers’ exposure to hazardous parenteral medications
from preparation in the pharmacy to administration with the patient
to disposal. The BD PhaSeal System is an airtight and leak-proof
CSTD that mechanically prohibits the transfer of environmental
contaminants into the system and the escape of drug or vapor
concentrations outside the system, thereby minimizing individual
and environmental exposure to drug vapor aerosols and spills.
Nursing Area/ Acute Care Adult Omnicell: Remote Med Selection and
Automated Dispensing Cabinet (ADC) Med Removal Nurse at bedside
pain assessment, request pain meds remotely, pain meds removed from
ADC, transport back to bedside in mobile medication cart.
BD: BD Simplist Ready-to-Administer Prefilled Syringes BD Simplist™
ready-to-administer pre-filled injectables supplied by BD Rx from
its state-of-the-art pharmaceutical plant are designed to improve
patient care and safety by decreasing the number of steps in the
traditional vial and syringe injection sequence, reducing the
potential risk of medication error.
B. Braun Medical, Inc: Break Out of the Pharmacy! DoseTrac® - Real
Time View for Error Prevention
B.Braun’s DoseTrac® Software displays all of your infusions – in
real time -giving you instant visibility to improve safety and
enabling our clients to achieve 100% library compliance, 88% alarm
reduction and 0 ADEs.
Baxter Healthcare: SIGMA Spectrum Pump Today, we will walk you
through our pump programming workflow and demonstrate the ease of
use and the safety features built into this pump. We will also
highlight safety features that are unique to our system. We are in
a Critical Care unit and we are going to start an infusion order to
start Dobutamine infusion on a patient.
Nursing Area/ Acute Care Pediatric
B. Braun Medical Inc.: Computerized Physician Order Entry of
Parenteral Nutrition Orders Pinnacle TPN Manager is the only CPOE
and Pharmacy software with Trissel’s Calcium-Phosphate Safety
Check. It automates calculations to streamline the prescribing of
parenteral nutrition from order entry to infusion from physician to
patient.
A production of the Intelligent Health Association 10THE
INTELLIGENT PHARMACY TM -
CareFusion: Med Labeling
Medication safety is enhanced when a barcoded label from the Pyxis
MedStation® ES system makes a generic medication patient-specific.
With an additional scan of the Alaris® system at the bedside,
closed-loop infusion safety is enabled between the computerized
physician order entry (CPOE) and the Alaris system. This
interoperability enables pre-population of infusion order
parameters from the electronic medical record (EMR) and wirelessly
sends infusion status to the EMR in near real time to simplify
documentation verification and sign-off.
Nursing Area/ Outpatient
CareFusion: Rowa Vmax With Rowa Visavia
The Rowa Vmax system streamlines medication management by
automating stock intake, recording expiry dates and batch numbers,
and providing storage and picking of orders, helping make hospital
workflow more efficient. With the Rowa Visavia terminal, patients
can pick up pre-ordered medications with 24/7 service and
consultation - transparent, quick and safe.
BD: BD PhaSeal Closed System Drug Transfer Device
BD PhaSeal™ Closed System Drug Transfer Device (CSTD) is proven to
reduce healthcare workers’ exposure to hazardous parenteral
medications from preparation in the pharmacy to administration with
the patient to disposal. The BD PhaSeal System is an airtight and
leak-proof CSTD that mechanically prohibits the transfer of
environmental contaminants into the system and the escape of drug
or vapor concentrations outside the system, thereby minimizing
individual and environmental exposure to drug vapor aerosols and
spills.
Cardinal Health: Outpatient Pharmacy Solutions With Bedside
Medication Delivery Outpatient Pharmacy Solutions enables
pharmacists to play a critical role in continuing patient care, by
ensuring patients receive and understand their medications before
they leave the hospital, while simultaneously driving revenue and
lowering employee benefit costs.
Take on Tomorrow. Visit us at ASHP Booth #589
Facing the reality of empty promises?
Omnicell was ranked Best in KLAS for Automated Medication
Dispensing Units from 2010 – 2014. Best in KLAS Awards – Medical
Equipment & Infrastructure Reports, 2006-2014. ©2014 KLAS
Enterprises LLC. All rights reserved. www.KLASresearch.com
When choosing medication automation, you want to make sure it
will
live up to expectations—now and in the future. The proven
Omnicell®
Unity enterprise platform delivers. It streamlines workfl ow by
integrat-
ing medication, supply, and central pharmacy automation systems on
a
single database, and keeps your technology up to date through
annual
software upgrades. Join the over 1,800 health care facilities that
are
saving time, reducing interruptions, and increasing medication
security
since choosing the Unity platform.
Omnicell—Proven, not just promised.
Ad_IPP Sponsor_10_2014.indd 1 10/17/14 1:23 PM
Rx A ss
et s?
The pharmacy is not often an optimized asset in the hospital. In
fact, it is often viewed simply as a utility or cost center. The
time has come for that to change, and the sooner the better.
Dramatic changes underway in healthcare - from the Affordable Care
Act to the sheer imperative to cut costs and improve performance -
are forcing hospital administrators to rethink how their hospitals
are leveraging resources and teams to achieve their strategic
agendas. For example, the old-fashioned way of seeing a hospital
pharmacy - as a break-even or marginally profitable order-filling
service department - can’t be sustained in today’s competitive
healthcare environment.
So what does it mean to leverage the hospital pharmacy as a
strategic asset? In short, a pharmacy should be expected to add
value to every aspect of a hospital’s strategic agenda. It can, and
should, contribute substantially to grow revenue, improve
efficiency, reduce waste, improve patient outcomes and create a
competitive advantage.
Exponential benefits - both financial and in quality of care - are
possible, especially when compared to departments and functions
that have not previously been optimized.
To transform the pharmacy into a strategic asset, hospitals don’t
have to reinvent the wheel. Many of the tools and resources exist,
yet are not being strategically implemented. First and foremost, it
requires executive sponsorship beyond the walls of the pharmacy,
and a multi- disciplinary team of care providers to be aligned and
to execute on strategic initiatives. This team would include
administration, physicians, nurses, and the pharmacy
leadership.
It also requires program management, with the development of
scorecards and key performance indicators. Lastly, it requires
pharmacy leadership that is engaged in key initiatives, committees
and teams across the hospi